Louisiana Board Report Sheds Light on DSCSA Compliance 
October 2, 2024

Louisiana Board Report Sheds Light on DSCSA Compliance 

A survey conducted by the Louisiana Board of Drug and Device Distributors (published on October 1st) found that a majority of trading partners have the necessary electronic systems to exchange data with other trading partners under the updated DSCSA compliance standards. The survey was sent to designated responsible persons (DRPs) at facilities that distribute drugs […]
Read More
Far From Compliant: Much Improvement Still Necessary for DSCSA Compliance
September 26, 2024

Far From Compliant: Much Improvement Still Necessary for DSCSA Compliance

Many Manufacturers are Failing to Meet DSCSA Requirements Published September 26th, 2024 The November 27th, 2024 deadline for DSCSA Compliance is just two months away. While many pharmaceutical partners have made tremendous efforts to adhere to updated guidelines, many remain far from compliant. DSCSA Compliance is a team effort; if certain trading partners fail to […]
Read More
FDA: No More Delay for Updated DSCSA Guidelines
September 12, 2024

FDA: No More Delay for Updated DSCSA Guidelines

The FDA has reaffirmed its commitment to the November 27, 2024, deadline for pharmaceutical partners to adhere to upcoming DSCSA regulations. With time running out, pharmaceutical stakeholders must assess their readiness and address any outstanding challenges. Ensuring accurate and complete data exchange between trading partners is critical for DSCSA compliance. Yet many partners remain unprepared […]
Read More
The Importance of DSCSA Compliance
September 4, 2024

The Importance of DSCSA Compliance

Many Unprepared for New Guidelines Published September 4th, 2024 With the November 27th, 2024 stabilization period deadline approaching quickly, pharmaceutical partners must be ready to adhere to new traceability and interoperability requirements. But a troubling number of partners haven’t made enough progress to reach these new standards, a statistic troubling to partners, the FDA, and […]
Read More
HDA Traceability Seminar Insights
August 28, 2024

HDA Traceability Seminar Insights

Published August 28th, 2024 The 2024 HDA – Healthcare Distribution Alliance Traceability Seminar was an amazing opportunity for pharmaceutical industry leaders to discuss DSCSA compliance challenges, and present innovative solutions to help partners remediate these challenges. Below, we discuss some important HDA Traceability Seminar Insights. One of the major takeaways from the conference was the […]
Read More